EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study

Michael H Burnam, Santosh Kumar Sinha, Mukesh Jitendra Jha, Sanjay Kumar Sharma, Amitesh Nagarwal, Rohit Chopra, Eli S Gang

ESC Heart Failure · 2026

DOI: 10.1093/eschf/xvaf020 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Michael H Burnam und 6 weiteren Autor:innen. Beteiligte Einrichtung: BaroPace, Inc., Issaquah, WA, USA. Hauptthemen laut MEDLINE: Hypertension, Heart Failure, Stroke Volume, Cardiac Pacing, Artificial. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BaroPace Inc. Issaquah, WA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Heart failure with preserved ejection fraction (HFpEF) represents approximately 50% of all heart failure cases and lacks effective treatments. Chronotropic incompetence contributes to exercise intolerance in these patients. This study evaluated the safety and efficacy of blood pressure–adaptive atrial pacing (BPAP) vs standard bradycardia pacing (STD) in hypertensive patients with HFpEF.

Methods

In this prospective, double-blind, randomized, self-controlled crossover study, 16 patients (mean age: 62.7 ± 10.9 years; 6% female; left ventricular ejection fraction 55.3 ± 3.8%) with treated hypertension and implanted dual-chamber pacemakers underwent two 3-week treatment phases (BPAP and STD) in random order. The BPAP algorithm–modulated atrial pacing rate in response to home blood pressure readings. Endpoints included the Minnesota Living With Heart Failure (MLWHF) score, New York Heart Association (NYHA) class, 6-minute walk test (6MWT), and modified Bruce treadmill test.

Results

BPAP improved MLWHF score by an additional 15% from baseline (P = .0288), whereas STD showed a non-significant 3% worsening. Exercise time increased significantly during BPAP (+83.2 ± 55.6 s, P = .005) but not during STD (+70.8 ± 84.4 s, P = .095). The 6MWT distance rose by 35.8 ± 29.9 m during BPAP (P = .003) vs minimal change with STD (+8.2 ± 40.1 m, P = .6). NYHA class improved in 55.6% of BPAP patients vs 11% with STD (P = .0455). Mean heart rate was higher during BPAP (83.8 ± 8.3 bpm) than STD (72.9 ± 12.0 bpm, P < .0001), with no difference in systolic blood pressure (137.5 ± 14.9 vs 138.6 ± 14.0 mmHg, P = .68). No adverse events occurred.

Conclusion

In hypertensive patients with HFpEF and implanted pacemakers, BPAP safely improved exercise capacity and functional status compared to standard pacing. The approach demonstrates feasibility of home-based blood pressure–modulated pacing for physiologic rate adaptation. (NCT06036186)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHeart FailureStroke VolumeCardiac Pacing, ArtificialBlood PressureExercise ToleranceHumansFemaleDouble-Blind MethodMaleProspective StudiesCross-Over StudiesMiddle AgedAgedTreatment OutcomeFollow-Up StudiesHeart AtriaHeart Rate

Stichwörter der Autor:innen

Cardiac PacingChronotropic incompetenceExercise toleranceHFpEFHypertensionRate adaptive atrial pacing

Autor:innen und Institutionen

  • BaroPace, Inc., Issaquah, WA, USA.
  • L.P.S Institute of Cardiology & Cardiac Surgery, GSVM Medical College, Swaroop Nagar, Kanpur, Uttar Pradesh, India.
  • Cardiology Department, Maharaja Agrasen Superspeciality Hospital, Jaipur, India.
  • Cardiology Department, NIMS Medical College, NIMS University, Jaipur, India.
  • Cardiology Department, C M Chopra Hospital & Heart Care Centre, Chomu, India.
  • Cardiovascular Research Foundation, Beverly Hills & Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, USA.

Förderung

  • BaroPace Inc. Issaquah, WA

Zitieren

APA

Burnam, M. H., Sinha, S. K., Jha, M. J., Sharma, S. K., Nagarwal, A., Chopra, R., & Gang, E. S. (2026). Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study. ESC Heart Failure. https://doi.org/10.1093/eschf/xvaf020

Vancouver

Burnam MH, Sinha SK, Jha MJ, Sharma SK, Nagarwal A, Chopra R, et al. Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study. ESC Heart Failure. 2026. doi:10.1093/eschf/xvaf020

BibTeX
@article{Burnam2026,
  author = {Burnam, Michael H and Sinha, Santosh Kumar and Jha, Mukesh Jitendra and Sharma, Sanjay Kumar and Nagarwal, Amitesh and Chopra, Rohit and Gang, Eli S},
  title = {Adaptive blood pressure–modulated atrial pacing in hypertensive HFpEF patients: a randomized, first-in-human study},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvaf020}
}
Kostenlos starten →